Investigating how time-restricted eating may prevent pancreatic cancer
TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION
This study is looking at how eating only during certain hours of the day might help stop pancreatic cancer in mice, and it aims to find out if this way of eating can change tumor growth and the body's immune system.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11193654 on NIH RePORTER |
What this research studies
This research explores the effects of time-restricted feeding (TRF) on preventing pancreatic cancer using a mouse model. The study aims to determine how fasting regimens can influence tumor growth, immune responses, and microbiome changes. By conducting both short-term and long-term TRF interventions, researchers hope to identify biomarkers that indicate the effectiveness of this dietary approach in preventing pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC).
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals at high risk for pancreatic cancer, such as those with a family history or genetic predispositions.
Not a fit: Patients who have already been diagnosed with advanced pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to dietary strategies that significantly reduce the risk of developing pancreatic cancer.
How similar studies have performed: Previous research has shown promising results with fasting regimens in cancer prevention, suggesting that this approach may be effective.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Vilar Sanchez, Eduardo — University of Tx Md Anderson Can Ctr
- Study coordinator: Vilar Sanchez, Eduardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.